The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Orally Disintegrating Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2029
Synopsis
The global Orally Disintegrating Drug market size was valued at USD 2013.7 million in 2022 and is forecast to a readjusted size of USD 3702.7 million by 2029 with a CAGR of 9.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The orally disintegrating drug market is being driven by several factors. One of the primary drivers is the growing demand for convenient and patient-friendly medication delivery methods. Orally disintegrating drugs offer an advantage over traditional oral tablets as they quickly dissolve in the mouth without the need for water, making them easier to administer, particularly for individuals with swallowing difficulties, pediatric patients, and the elderly. Additionally, the increasing prevalence of chronic diseases and the need for efficient and immediate drug absorption have fueled the demand for orally disintegrating drugs. Furthermore, advancements in formulation technologies and taste-masking techniques have improved the palatability of these drugs, enhancing patient compliance. Overall, the demand for orally disintegrating drugs is driven by the need for convenience, improved patient experience, and enhanced drug delivery options in the pharmaceutical market.
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
This report is a detailed and comprehensive analysis for global Orally Disintegrating Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Orally Disintegrating Drug market size and forecasts, in consumption value ($ Million), 2018-2029
Global Orally Disintegrating Drug market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Orally Disintegrating Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Orally Disintegrating Drug market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Orally Disintegrating Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Orally Disintegrating Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson and Johnson, GSK, Otsuka, Vartris and Teva, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Orally Disintegrating Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Anti-Psychotics Drug
Anti-Epileptics Drug
Other
Market segment by Application
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Other
Market segment by players, this report covers
Johnson and Johnson
GSK
Otsuka
Vartris
Teva
Pfizer
Eli Lilly and Company
Merck
Eisai
AstraZeneca
Bristol-Myers Squibb
Conquer
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Orally Disintegrating Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Orally Disintegrating Drug, with revenue, gross margin and global market share of Orally Disintegrating Drug from 2018 to 2023.
Chapter 3, the Orally Disintegrating Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Orally Disintegrating Drug market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Orally Disintegrating Drug.
Chapter 13, to describe Orally Disintegrating Drug research findings and conclusion.
The global Orally Disintegrating Drug market size was valued at USD 2013.7 million in 2022 and is forecast to a readjusted size of USD 3702.7 million by 2029 with a CAGR of 9.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The orally disintegrating drug market is being driven by several factors. One of the primary drivers is the growing demand for convenient and patient-friendly medication delivery methods. Orally disintegrating drugs offer an advantage over traditional oral tablets as they quickly dissolve in the mouth without the need for water, making them easier to administer, particularly for individuals with swallowing difficulties, pediatric patients, and the elderly. Additionally, the increasing prevalence of chronic diseases and the need for efficient and immediate drug absorption have fueled the demand for orally disintegrating drugs. Furthermore, advancements in formulation technologies and taste-masking techniques have improved the palatability of these drugs, enhancing patient compliance. Overall, the demand for orally disintegrating drugs is driven by the need for convenience, improved patient experience, and enhanced drug delivery options in the pharmaceutical market.
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
This report is a detailed and comprehensive analysis for global Orally Disintegrating Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Orally Disintegrating Drug market size and forecasts, in consumption value ($ Million), 2018-2029
Global Orally Disintegrating Drug market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Orally Disintegrating Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Orally Disintegrating Drug market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Orally Disintegrating Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Orally Disintegrating Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson and Johnson, GSK, Otsuka, Vartris and Teva, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Orally Disintegrating Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Anti-Psychotics Drug
Anti-Epileptics Drug
Other
Market segment by Application
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Other
Market segment by players, this report covers
Johnson and Johnson
GSK
Otsuka
Vartris
Teva
Pfizer
Eli Lilly and Company
Merck
Eisai
AstraZeneca
Bristol-Myers Squibb
Conquer
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Orally Disintegrating Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Orally Disintegrating Drug, with revenue, gross margin and global market share of Orally Disintegrating Drug from 2018 to 2023.
Chapter 3, the Orally Disintegrating Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Orally Disintegrating Drug market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Orally Disintegrating Drug.
Chapter 13, to describe Orally Disintegrating Drug research findings and conclusion.
Index1 Market Overview
1.1 Product Overview and Scope of Orally Disintegrating Drug
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Orally Disintegrating Drug by Type
1.3.1 Overview: Global Orally Disintegrating Drug Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Orally Disintegrating Drug Consumption Value Market Share by Type in 2022
1.3.3 Anti-Psychotics Drug
1.3.4 Anti-Epileptics Drug
1.3.5 Other
1.4 Global Orally Disintegrating Drug Market by Application
1.4.1 Overview: Global Orally Disintegrating Drug Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 CNS Diseases
1.4.3 Gastrointestinal Diseases
1.4.4 CVS Diseases
1.4.5 Other
1.5 Global Orally Disintegrating Drug Market Size & Forecast
1.6 Global Orally Disintegrating Drug Market Size and Forecast by Region
1.6.1 Global Orally Disintegrating Drug Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Orally Disintegrating Drug Market Size by Region, (2018-2029)
1.6.3 North America Orally Disintegrating Drug Market Size and Prospect (2018-2029)
1.6.4 Europe Orally Disintegrating Drug Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Orally Disintegrating Drug Market Size and Prospect (2018-2029)
1.6.6 South America Orally Disintegrating Drug Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Orally Disintegrating Drug Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Johnson and Johnson
2.1.1 Johnson and Johnson Details
2.1.2 Johnson and Johnson Major Business
2.1.3 Johnson and Johnson Orally Disintegrating Drug Product and Solutions
2.1.4 Johnson and Johnson Orally Disintegrating Drug Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Johnson and Johnson Recent Developments and Future Plans
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Orally Disintegrating Drug Product and Solutions
2.2.4 GSK Orally Disintegrating Drug Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 GSK Recent Developments and Future Plans
2.3 Otsuka
2.3.1 Otsuka Details
2.3.2 Otsuka Major Business
2.3.3 Otsuka Orally Disintegrating Drug Product and Solutions
2.3.4 Otsuka Orally Disintegrating Drug Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Otsuka Recent Developments and Future Plans
2.4 Vartris
2.4.1 Vartris Details
2.4.2 Vartris Major Business
2.4.3 Vartris Orally Disintegrating Drug Product and Solutions
2.4.4 Vartris Orally Disintegrating Drug Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Vartris Recent Developments and Future Plans
2.5 Teva
2.5.1 Teva Details
2.5.2 Teva Major Business
2.5.3 Teva Orally Disintegrating Drug Product and Solutions
2.5.4 Teva Orally Disintegrating Drug Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Teva Recent Developments and Future Plans
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Orally Disintegrating Drug Product and Solutions
2.6.4 Pfizer Orally Disintegrating Drug Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Pfizer Recent Developments and Future Plans
2.7 Eli Lilly and Company
2.7.1 Eli Lilly and Company Details
2.7.2 Eli Lilly and Company Major Business
2.7.3 Eli Lilly and Company Orally Disintegrating Drug Product and Solutions
2.7.4 Eli Lilly and Company Orally Disintegrating Drug Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Eli Lilly and Company Recent Developments and Future Plans
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business
2.8.3 Merck Orally Disintegrating Drug Product and Solutions
2.8.4 Merck Orally Disintegrating Drug Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Merck Recent Developments and Future Plans
2.9 Eisai
2.9.1 Eisai Details
2.9.2 Eisai Major Business
2.9.3 Eisai Orally Disintegrating Drug Product and Solutions
2.9.4 Eisai Orally Disintegrating Drug Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Eisai Recent Developments and Future Plans
2.10 AstraZeneca
2.10.1 AstraZeneca Details
2.10.2 AstraZeneca Major Business
2.10.3 AstraZeneca Orally Disintegrating Drug Product and Solutions
2.10.4 AstraZeneca Orally Disintegrating Drug Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 AstraZeneca Recent Developments and Future Plans
2.11 Bristol-Myers Squibb
2.11.1 Bristol-Myers Squibb Details
2.11.2 Bristol-Myers Squibb Major Business
2.11.3 Bristol-Myers Squibb Orally Disintegrating Drug Product and Solutions
2.11.4 Bristol-Myers Squibb Orally Disintegrating Drug Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.12 Conquer
2.12.1 Conquer Details
2.12.2 Conquer Major Business
2.12.3 Conquer Orally Disintegrating Drug Product and Solutions
2.12.4 Conquer Orally Disintegrating Drug Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Conquer Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Orally Disintegrating Drug Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Orally Disintegrating Drug by Company Revenue
3.2.2 Top 3 Orally Disintegrating Drug Players Market Share in 2022
3.2.3 Top 6 Orally Disintegrating Drug Players Market Share in 2022
3.3 Orally Disintegrating Drug Market: Overall Company Footprint Analysis
3.3.1 Orally Disintegrating Drug Market: Region Footprint
3.3.2 Orally Disintegrating Drug Market: Company Product Type Footprint
3.3.3 Orally Disintegrating Drug Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Orally Disintegrating Drug Consumption Value and Market Share by Type (2018-2023)
4.2 Global Orally Disintegrating Drug Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Orally Disintegrating Drug Consumption Value Market Share by Application (2018-2023)
5.2 Global Orally Disintegrating Drug Market Forecast by Application (2024-2029)
6 North America
6.1 North America Orally Disintegrating Drug Consumption Value by Type (2018-2029)
6.2 North America Orally Disintegrating Drug Consumption Value by Application (2018-2029)
6.3 North America Orally Disintegrating Drug Market Size by Country
6.3.1 North America Orally Disintegrating Drug Consumption Value by Country (2018-2029)
6.3.2 United States Orally Disintegrating Drug Market Size and Forecast (2018-2029)
6.3.3 Canada Orally Disintegrating Drug Market Size and Forecast (2018-2029)
6.3.4 Mexico Orally Disintegrating Drug Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Orally Disintegrating Drug Consumption Value by Type (2018-2029)
7.2 Europe Orally Disintegrating Drug Consumption Value by Application (2018-2029)
7.3 Europe Orally Disintegrating Drug Market Size by Country
7.3.1 Europe Orally Disintegrating Drug Consumption Value by Country (2018-2029)
7.3.2 Germany Orally Disintegrating Drug Market Size and Forecast (2018-2029)
7.3.3 France Orally Disintegrating Drug Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Orally Disintegrating Drug Market Size and Forecast (2018-2029)
7.3.5 Russia Orally Disintegrating Drug Market Size and Forecast (2018-2029)
7.3.6 Italy Orally Disintegrating Drug Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Orally Disintegrating Drug Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Orally Disintegrating Drug Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Orally Disintegrating Drug Market Size by Region
8.3.1 Asia-Pacific Orally Disintegrating Drug Consumption Value by Region (2018-2029)
8.3.2 China Orally Disintegrating Drug Market Size and Forecast (2018-2029)
8.3.3 Japan Orally Disintegrating Drug Market Size and Forecast (2018-2029)
8.3.4 South Korea Orally Disintegrating Drug Market Size and Forecast (2018-2029)
8.3.5 India Orally Disintegrating Drug Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Orally Disintegrating Drug Market Size and Forecast (2018-2029)
8.3.7 Australia Orally Disintegrating Drug Market Size and Forecast (2018-2029)
9 South America
9.1 South America Orally Disintegrating Drug Consumption Value by Type (2018-2029)
9.2 South America Orally Disintegrating Drug Consumption Value by Application (2018-2029)
9.3 South America Orally Disintegrating Drug Market Size by Country
9.3.1 South America Orally Disintegrating Drug Consumption Value by Country (2018-2029)
9.3.2 Brazil Orally Disintegrating Drug Market Size and Forecast (2018-2029)
9.3.3 Argentina Orally Disintegrating Drug Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Orally Disintegrating Drug Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Orally Disintegrating Drug Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Orally Disintegrating Drug Market Size by Country
10.3.1 Middle East & Africa Orally Disintegrating Drug Consumption Value by Country (2018-2029)
10.3.2 Turkey Orally Disintegrating Drug Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Orally Disintegrating Drug Market Size and Forecast (2018-2029)
10.3.4 UAE Orally Disintegrating Drug Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Orally Disintegrating Drug Market Drivers
11.2 Orally Disintegrating Drug Market Restraints
11.3 Orally Disintegrating Drug Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Orally Disintegrating Drug Industry Chain
12.2 Orally Disintegrating Drug Upstream Analysis
12.3 Orally Disintegrating Drug Midstream Analysis
12.4 Orally Disintegrating Drug Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
